291 related articles for article (PubMed ID: 7878763)
21. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Onodera K; Hancock WW; Graser E; Lehmann M; Sayegh MH; Strom TB; Volk HD; Kupiec-Weglinski JW
J Immunol; 1997 Feb; 158(4):1572-81. PubMed ID: 9029092
[TBL] [Abstract][Full Text] [Related]
22. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
[TBL] [Abstract][Full Text] [Related]
23. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
24. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
[TBL] [Abstract][Full Text] [Related]
25. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
[No Abstract] [Full Text] [Related]
26. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
Takayashiki T; Asakura H; Ku G; Kataoka M; Flye MW
Surgery; 2005 Aug; 138(2):254-60. PubMed ID: 16153434
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
J Surg Res; 1995 Jul; 59(1):91-6. PubMed ID: 7630143
[TBL] [Abstract][Full Text] [Related]
28. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
29. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
30. Significant changes in the alloantibody after lung transplantation in the cyclosporine treated rat model.
Yamane M; Sano Y; Shimizu N
Transpl Immunol; 2004 Jan; 12(2):143-50. PubMed ID: 14967312
[TBL] [Abstract][Full Text] [Related]
31. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
Majoor GD; Van Breda Vriesman PJ
Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
[TBL] [Abstract][Full Text] [Related]
32. [Immune tolerance induced by combined heart-thymus transplantation with intrathymic inoculation of thymocytes in rats].
Xiong HB; Xia SS; Huang ZF; Wen H; Ye QF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):85-90. PubMed ID: 16562683
[TBL] [Abstract][Full Text] [Related]
33. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
Coito AJ; Binder J; de Sousa M; Kupiec-Weglinski JW
Transplantation; 1994 Feb; 57(4):599-605. PubMed ID: 8116048
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
35. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
36. Successful experimental heart transplantation without immunosuppressive drugs.
Kline GM; Shen Z; Mohiuddin M; Ruggiero V; Rostami S; DiSesa VJ
J Heart Lung Transplant; 1993; 12(3):388-93. PubMed ID: 8329408
[TBL] [Abstract][Full Text] [Related]
37. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
38. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
Chowdhury NC; Fawwaz RA; Oluwole SF
J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
[TBL] [Abstract][Full Text] [Related]
39. Fetal inoculation with donor cells in cardiac xenotransplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
[TBL] [Abstract][Full Text] [Related]
40. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
